Detail akcie Takeda Pharmactl Depository Receipt online

Business Summary: Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, Takeda Pharmaceutical Co Ltd (ADR) revenues increased 7% to Y4.582T. Net income decreased 25% to Y107.93B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Total Selling, General and Administrativ increase of 5% to Y1.105T (expense).